Large gap with delayed quotes
Analysis date: 01.07.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 01.07.2025.
Interest
Weak
Weak
Two stars since 01.07.2025.
Earnings Rev Trend
-0.10
-0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 11.04.2025 at a price of 120.40.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Negative
Negative
The forty day technical trend is negative since 07.02.2025.
4wk Rel Perf
3.64%
3.64%
The four-week dividend-adjusted overperformance versus SP500 is 3.64%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 3.23%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.74%.
Mkt Cap in $bn
4.93
4.93
With a market capitalization between $2 & $8bn, ONTO INNOVATION is considered a mid-cap stock.
G/PE Ratio
0.88
0.88
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
16.42
16.42
The estimated PE is for the year 2027.
LT Growth
14.38%
14.38%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
6
6
Over the last seven weeks, an average of 6 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
219
219
For 1% of index variation, the stock varies on average by 2.19%.
Correlation
0.63
0.63
62.75% of stock movements are explained by index variations.
Value at Risk
34.91
34.91
The value at risk is estimated at USD 34.91. The risk is therefore 34.83%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
01.12.2023
01.12.2023